Nabota

Regular price €70,00
Sale price €70,00 Regular price
Unit price
Ask a question

Ask a Question

* Required fields

Size guide Share
PRODUCT DESCRIPTION
RETURN POLICY

Nabota 200UI - Botulinum Toxin Type A

Nabota 200UI is a type A botulinum toxin developed by
Daewoong Pharmaceutical Co., Ltd. and approved by the
U.S. Food and Drug Administration (FDA). As the first
Korean botulinum toxin to enter the U.S. market, Nabota
competes directly with Botox as a cost-effective alternative
without requiring changes in handling this medical product.

Nabota botulinum toxin type A is used to reduce the appearance
of wrinkles caused by uncontrolled facial muscle activity
and active facial expressions. It is a proven, safe product
developed by Daewoong Pharmaceutical Co., Ltd., South Korea,
with over 30 years of experience in biotechnology.

Key Benefits:

  • Rapid action

  • High standard of purification

  • Long-lasting effects

  • Preserves natural facial expressions

  • High safety profile

Application Areas:

  • Smoothing wrinkles in the eyebrows, nasolabial folds,
    around the eyes and mouth, and periorbital zones

  • Blepharospasm treatment

  • Hyperhidrosis treatment (excessive sweating)

  • Botox lifting for facial rejuvenation

Main Ingredients:

  • Clostridium Botulinum Toxin A (strain: Clostridium Botulinum CBFC26)

Packing Unit:

  • 1 vial (200 or 100 units per box)

We have a 30-day return policy, which means you have 30 days after receiving your item to request a return.

To be eligible for a return, your item must be in the same condition that you received it, unworn or unused, with tags, and in its original packaging. You’ll also need the receipt or proof of purchase.

To start a return, you can contact us at k.karathanasis1990@gmail.com.

If your return is accepted, we’ll send you a return shipping label, as well as instructions on how and where to send your package. Items sent back to us without first requesting a return will not be accepted.

You can always contact us for any return question at k.karathanasis1990@gmail.com.